Replay available

Alleima AB (publ) (ALLEI) Q3 2025 Earnings Call

Alleima AB (publ) (STO: ALLEI) Q3 2025 earnings conference call, held 2025-10-22. Replay captured from the company's public earnings webcast.

Wed, October 22, 2025 at 7:00 AMendedReplay
Alleima AB (publ) (ALLEI) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Göran Björkman

President and CEO

Andreas Eriksson

Investor Relations Officer

Anders Åkerbom

Analyst at Nordia

Caleb Solomon

Analyst at SEB

Adrian Gilani

Analyst at ABG

Victor Trostem

Analyst at Danske Bank

Igor Zubik

Analyst at DNB Canergy

Johan Eriksson

Chief Financial Officer

Replay transcript excerpt

Hi, everyone, and welcome to the presentation of Alema's interim report for the third quarter 2025. My name is Andreas Eriksson, investor relations officer. I'm joined today by Göran Björkman, president and CEO, and Johan Eriksson, CFO. Göran and Johan will walk you through the operational and financial highlights of the quarter. And following the presentation, we will open up for a Q&A session. You're welcome to ask questions via the conference call or submit them through the webcast interface. And the presentation materials are available for download at aleima.com. As always, safety is a top priority for us. And I trust that you are familiar with the safety procedures at your current location. And with that, I'll hand over to you, Jörg. Thank you, Andreas. And hi, everyone. And thank you for listening. Let me start with the highlights of the quarter. The geopolitical situation is still turbulent and we are still seeing a market with continued uncertainties. Customers are prolonging their investment decision and I would say the overall kind of wait and see attitude remains. And I think this is particularly visible in Europe, but also in Americas, where volumes related to the more short cycle businesses like industrial, chem, petrochem, and also industrial heating are low. Despite this, I think our underlying performance is decent, given the challenging environment, and we are clearly benefiting from a diversified exposure. Order intake rolling 12, declined 1% organically, and revenues were flat year over year. Backlog remains solid in important segments like oil and gas, nuclear and medical, with good product mix and visibility for the near-term future. But as I stated in the more short-cycle business and done especially in Europe and America, the backlog is weaker....

More from Alleima Ab